Square Pharma vice chairman to purchase shares worth Tk33cr | The Business Standard
Skip to main content
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Wednesday
July 09, 2025

Sign In
Subscribe
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
WEDNESDAY, JULY 09, 2025
Square Pharma vice chairman to purchase shares worth Tk33cr

Stocks

TBS Report
12 March, 2025, 10:10 pm
Last modified: 12 March, 2025, 10:11 pm

Related News

  • Square Pharma director to buy company shares worth Tk32cr
  • Square Pharma's two directors to buy 20 lakh shares worth Tk42 crore
  • Square Pharma expands global footprint with entry into Philippine market
  • Square Pharma to invest $1 million in Philippines
  • Square Pharma declares record dividend, Tk400cr expansion plan

Square Pharma vice chairman to purchase shares worth Tk33cr

At the current market price of Tk218.90 per share, the transaction is estimated to be worth approximately Tk33 crore

TBS Report
12 March, 2025, 10:10 pm
Last modified: 12 March, 2025, 10:11 pm
Square Pharma vice chairman to purchase shares worth Tk33cr

Ratna Patra, vice chairman of Square Pharmaceuticals, has announced plans to acquire 15 lakh shares of the company at the prevailing market price within the next 30 days. 

The announcement was made through a disclosure on the Dhaka Stock Exchange (DSE) on Wednesday (12 March). The shares will be purchased either from the public market or the block market of the Dhaka bourse.

At the current market price of Tk218.90 per share, the transaction is estimated to be worth approximately Tk33 crore. 

The Business Standard Google News Keep updated, follow The Business Standard's Google news channel

This move follows similar announcements by Square Pharma Chairman Samuel S Chowdhury and Managing Director Tapan Chowdhury, who each declared their intention to purchase 15 lakh shares of the company earlier.

According to DSE data, between 2020 and 2025, four directors of Square Pharma collectively increased their holdings in the company by acquiring 1.06 crore shares. As a result, the combined stake of sponsors and directors in the company has risen significantly, from 34.43% to 42.91%.

This series of share acquisitions by key executives reflects their confidence in the company's growth prospects and long-term stability. Square Pharmaceuticals, a leading player in the country's pharmaceutical industry, continues to demonstrate strong performance, making it an attractive investment for its directors and shareholders alike, according to market insiders.

Meanwhile, Square Pharmaceuticals reported a 13% year-on-year growth in net profit and a 6% increase in net revenue in the first half of the current fiscal year, ending in December 2024, according to its financial report. 

During the July-December period, the company's net revenue rose to Tk3,771.77 crore, up from Tk3,555.25 crore in the same period of the previous fiscal year. In addition, its net profit increased to Tk1,269.64 crore from Tk1,124.59 crore.

Bangladesh

Square Pharmaceuticals Ltd

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • CA orders police, BGB, Ansar to complete election preparation by December
    CA orders police, BGB, Ansar to complete election preparation by December
  • File photo of Election Commission building in Agargaon. Photo: Rajib Dhar/TBS
    EC bars political parties from using 'Shapla' as electoral symbol
  • Graphics: TBS
    Central bank makes startup loans available at 4% interest for Bangladeshis aged 21

MOST VIEWED

  • None saw it coming: What went wrong in Bangladesh’s tariff negotiation with US 
    None saw it coming: What went wrong in Bangladesh’s tariff negotiation with US 
  • File Photo: Rajib Dhar/TBS
    Bangladesh faces economic impact as US introduces 35% tariff on exports
  • Representational image. Photo: Collected
    Bangladesh reserves above $24b even after making $2b ACU payment 
  • Electric buses for capital: Tk2,500cr to be spent in 2 years
    Electric buses for capital: Tk2,500cr to be spent in 2 years
  • Representational image. Photo: TBS
    35% US tariff to be disastrous for Bangladesh's exports, say economists and exporters
  • Clashes took place between police and protesters in Sylhet on 2 August. Photo: TBS
    Hasina authorised deadly crackdown on protesters during 2024 July uprising, BBC verifies leaked audio

Related News

  • Square Pharma director to buy company shares worth Tk32cr
  • Square Pharma's two directors to buy 20 lakh shares worth Tk42 crore
  • Square Pharma expands global footprint with entry into Philippine market
  • Square Pharma to invest $1 million in Philippines
  • Square Pharma declares record dividend, Tk400cr expansion plan

Features

Women are forced to fish in saline waters every day, risking their health to provide for their families. Photo: TBS

How Mongla’s women are bearing the brunt of rising salinity

2h | Panorama
Dr Mostafa Abid Khan. Sketch: TBS

Actual impact will depend on how US retailers respond: Mostafa Abid Khan

1d | Economy
Thousands gather to form Bangla Blockade in mass show of support. Photo: TBS

Rebranding rebellion: Why ‘Bangla Blockade’ struck a chord

2d | Panorama
The Mitsubishi Xpander is built with families in mind, ready to handle the daily carpool, grocery runs, weekend getaways, and everything in between. PHOTO: Akif Hamid

Now made-in-Bangladesh: 2025 Mitsubishi Xpander

2d | Wheels

More Videos from TBS

What can be done to counter the impact of US tariffs?

What can be done to counter the impact of US tariffs?

32m | Podcast
Elections can be held before Ramadan if preparations are complete: Press Secretary

Elections can be held before Ramadan if preparations are complete: Press Secretary

1h | TBS Today
US signals tougher action if Gaza ceasefire talks fail

US signals tougher action if Gaza ceasefire talks fail

Now | TBS World
China-Pakistan-Bangladesh closeness threatens India's security

China-Pakistan-Bangladesh closeness threatens India's security

1h | TBS World
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net